Zhejiang Hisun Pharmaceutical Co., Ltd. (002099)

Overview

Zhejiang Hisoar Pharmaceutical Co., Ltd. is a reputable pharmaceutical company with both domestic and international operations. Founded in 1966, the company has established a strong presence in the pharmaceutical industry, thanks to its comprehensive range of products and services. Based in Taizhou, China, Hisoar Pharmaceutical has grown to become a key player, offering innovative solutions in pharmaceuticals, fine chemicals, and more. Their expertise spans the development, production, and marketing of a variety of pharmaceutical products, catering to the needs of healthcare providers and patients worldwide.

Products and Services

• Antibiotics: Hisoar Pharmaceutical specializes in the development and manufacture of antibiotic medications, which are vital in treating various bacterial infections. These play a crucial role in healthcare settings, addressing the needs for effective antimicrobial therapy.
• Cardiovascular Products: The company offers a range of products aimed at supporting heart health and treating cardiovascular conditions. These products are designed to meet the growing demand for effective treatments in managing heart diseases.
• Hypoglycemic Products: Focusing on diabetes care, Hisoar Pharmaceutical provides hypoglycemic products to help manage blood sugar levels in individuals with diabetes. This category underscores the company’s commitment to addressing chronic health conditions.
• Fine Chemicals: Beyond pharmaceuticals, Hisoar Pharmaceutical is engaged in the production of fine chemicals, which have applications in various industries, indicating the company's versatile approach to chemical production.
• Dyes: The company manufactures dyes used in various applications, including industrial processes and products. This diversification illustrates Hisoar’s capacity to serve different market segments with its chemical expertise.
• Intermediates: Hisoar Pharmaceutical supplies intermediates that are crucial in the pharmaceutical manufacturing process, offering essential compounds that facilitate the production of active pharmaceutical ingredients (APIs).
• Clindamycin Products: A specific focus on clindamycin products highlights Hisoar’s capability in producing effective antibiotic treatments, catering to the needs for clindamycin-based therapies in the medical field.

In addition to these products, Hisoar Pharmaceutical extends its services to include pharmaceutical manufacturing, dyestuff production, and other related services. This broad range of offerings demonstrates the company’s integrated approach to catering to the healthcare and chemical industries.